959162-99-3

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
6-chloro-4-(ethylamino)-3-Pyridinemethanol is used as a key intermediate in the synthesis of various pharmaceuticals for its potential biological activity. It aids in the development of new drugs by facilitating interactions with specific molecular targets, contributing to the advancement of medicinal chemistry.
Used in Agrochemicals:
In the agrochemical industry, 6-chloro-4-(ethylamino)-3-Pyridinemethanol is used as a component in the formulation of pesticides and other agricultural chemicals. Its unique molecular structure allows it to contribute to the effectiveness of these products, enhancing crop protection and yield.
Used in Dyes and Pigments:
6-chloro-4-(ethylamino)-3-Pyridinemethanol is also employed in the production of dyes and pigments due to its chemical properties. It serves as a building block for creating a range of colorants used in various applications, including textiles, plastics, and printing inks, adding vibrancy and stability to these products.

Upstream product

• 6975-44-6 4,6-dihydroxynicotinic acid ethyl ester 
• 105-50-0 diethyl 1,3-acetonedicarboxylate 
• 40296-46-6 ethyl 4,6-dichloronicotinate 
• 959162-97-1 6-chloro-4-ethylamino-nicotinic acid ethyl ester 

Downstream Products

• 959163-01-0 6-chloro-4-ethylamino-pyridine-3-carbaldehyde 
• 1588422-11-0 C₂₂H₁₉FN₄O 
• 1588424-47-8 7-chloro-3-cyclohexyl-1-ethyl-1H-[1,6]naphthyridin-2-one 
• 1588424-46-7 7-chloro-1-ethyl-3-thiophen-2-yl-1H-[1,6]naphthyridin-2-one 
• 1588421-90-2 1-ethyl-7-{6-[4-(2-hydroxyethyl)-piperazin-1-yl]-2-methylpyrimidin-4-ylamino}-3-phenyl-1H-[1,6]naphthyridin-2-one 
• 1588421-89-9 1-ethyl-7-[5-(morpholine-4-carbonyl)pyridin-2-ylamino]-3-phenyl-1H-[1,6]naphthyridin-2-one 
• 1588424-29-6 7-chloro-1-ethyl-3-(4-fluoro-2,6-dimethylphenyl)-1,6-naphthyridin-2(1H)-one 
• 1588424-28-5 7-chloro-1-ethyl-3-(4-fluoro-2,6-dimethylphenyl)-1,6-naphthyridin-2(1H)-imine 
• 1588424-27-4 C₁₆H₁₁ClF₂N₂O₂ 
• 1588424-26-3 C₁₇H₁₃ClF₂N₂O₂ 
• 1588424-25-2 C₁₇H₁₄ClF₂N₃O 
• 1588424-24-1 C₁₆H₁₂ClFN₂O₂ 
• 1588424-23-0 7-chloro-1-ethyl-3-(2-fluoro-5-methoxyphenyl)-1,6-naphthyridin-2(1H)-one 
• 1588424-22-9 7-chloro-1-ethyl-3-(2-fluoro-5-methoxyphenyl)-1,6-naphthyridin-2(1H)-imine 

Relevant academic research and scientific papers

FGFR INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

A compound having a structure of formula (I) and a preparation method therefor, and a use of the compound serving as an FGFR inhibitor for treating tumors, cancers, myeloproliferative diseases, bone or chondrocyte disorders, and hypophosphatemia.

GEM-DISUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IDH INHIBITORS

The present invention relates to certain gem-disubstituted heterocyclic compounds, which modulate the activity of Isocitrate Dehydrogenase (IDH). The compounds of this invention are therefore useful in treating diseases caused by mutated IDH1 and/or mutat

HETEROCONDENSED PYRIDONES COMPOUNDS AND THEIR USE AS IDH INHIBITORS

The present invention relates to certain substituted heterocondensed pyridone analogues of formula (I) which modulate the activity of Isocitrate Dehydrogenase (IDH). The compounds of this invention are therefore useful in treating diseases caused by mutat

Inhibitors of the fibroblast growth factor receptor

Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of FGFR-4.

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of FGFR-4.

MULTIPLE KINASE PATHWAY INHIBITORS

Kinase with inhibitory activity against kinases disposed in multiple signaling pathways and their therapeutic uses.

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

The invention relates to dihydronaphthyridines and related compounds; compositions comprising an effective amount of a dihydronaphthyridine or a related compound; and methods for treating or preventing proliferative diseases comprising the administration of an effective amount of a dihydronaphthyridine or a related compound.

DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The invention relates to dihydronaphthyridines and related compounds; compositions comprising an effective amount of a dihydronaphthyridine or a related compound; and methods for treating or preventing proliferative diseases comprising the administration of an effective amount of a dihydronaphthyridine or a related compound. The present invention discloses the unexpected utility of compounds that inhibit cKIT kinase across a broad range of c-KIT mutations, including complex occurrences of primary mutations (KIT exon 9 or 11) and secondary KIT mutations (exons 13, 14, 17 and 18) that may arise in individual, refractory GIST patients. Also unexpected is the utility of compounds of the present invention to inhibit the problematic exon 17 D816V c-KIT mutation, for which there is currently no effective therapy.

COMPOSITIONS AND METHODS FOR FGF RECEPTOR KINASES INHIBITORS

Described are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or prevent disease or disordered associated with abnormal or deregulated kinase activity, particularly diseases or disorders that